Clinical Trials Logo

Locally Recurrent Cancer clinical trials

View clinical trials related to Locally Recurrent Cancer.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT03813394 Not yet recruiting - Clinical trials for Metastatic Nasopharyngeal Cancer

Bevacizumab and Pembrolizumab Combination in EBER-ISH Positive NPC

2018/00947
Start date: May 1, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This is a single center, randomized, phase Ib/II open-label study of pembrolizumab (pembro or MK-3475) with or without bevacizumab in patients with recurrent non-curable or metastatic nasopharyngeal carcinoma (NPC).